chronic migraineCMatogepantBTX-ATOATOm
…elevance Results suggest that the effectiveness of atogepant in chronic migraine, in terms of reducing monthly migraine days, is comparable betw…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 2,701–2,760 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
chronic obstructive pulmonary disease (COPD)3chronic renal disease3chronic subdural haematoma3chronic thromboembolic pulmonary hypertension3colonic polyps3common bile duct stones3common cold3congenital adrenal hyperplasia3congenital heart defects3connective tissue disease-associated ILD3coronary plaques3coronavirus disease3critically ill children3depressive disorders3diabetes mellitus (DM)3diabetes-free3diabetic foot ulcer3diabetic macular edema3diffuse cutaneous systemic sclerosis3dry eye syndrome3endometrial stromal sarcoma3exertional dyspnoea3extensive-stage small-cell lung cancer3familial Mediterranean fever3fibrotic lung diseases3generalized myasthenia gravis3geographic atrophy3graft-versus-host disease (GVHD)3granulomatous polyangiitis3haemoglobinopathies3haemopneumothorax3haemothorax3healthcare-associated infections3hepatocellular carcinomas3herpes simplex virus (HSV) encephalitis3herpes zoster (HZ)3heterozygous familial hypercholesterolaemia3human cancer3hypertensive crisis3hypertensive disorders3hyperuricaemia3hypoxic injury3infectious and non-communicable diseases3inflammatory myopathy3intellectual and developmental disabilities3internal carotid artery (ICA) aneurysms3intra-abdominal sepsis3invasive pneumococcal disease3ischemic strokes3large-vessel occlusion stroke3large-vessel occlusive acute ischemic stroke (LVO-AIS)3left hemiparesis3liver3lung and colon cancer3lymphadenopathy3lymphatic filariasis3malignant distal biliary obstruction3malignant neoplasms3mania3marginal zone lymphoma3
Articles mentioning diseases
23,712 articles · page 401 of 1976diabetic macular oedemaneovascular age-related macular degenerationnAMDDMEfaricimabranibizumabafliberceptbrolucizumab
…ment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME). Unlike previous anti-VEGF agents, faricimab targets both…
hepatic impairmentcirrhosishepatic insufficiencybeta-blockerssecondary care hospitalpsycholepticshypolipidemic agentsSociety of Hospital Pharmacists of Australia
…y, is limited. The adaptation of drug dosages in the context of hepatic impairment is a complex issue that lacks comprehensive discussion in curre…
ABSSSIosteomyelitisspondylodiscitisacute bacterial skin and skin structure infectionsprosthetic joint infectioncomplex infectionsdalbavancinAmbulatory consolidation therapyHospital Pharmacy Department
…odality. Off-label use was defined as any indication other than ABSSSI. A stepwise backward selection linear regression model was used…
acute severe hyperkalaemiachronic hyperkalaemiaacute hyperkalaemiarenal failurecalcium gluconateinsulinintravenous glucoseSZCtertiary hospital
…tiation.SZC appears to be an effective adjunctive treatment for acute severe hyperkalaemia in patients with renal failure who are already receiving standa…
migraineepisodic migraineatogepant
…ly approved oral calcitonin gene-related peptide antagonist for migraine prophylaxis in adults. Real-world data on its efficacy and safe…
multiple sclerosisMSSPMSRRMSofatumumabocrelizumabteriflunomidenatalizumab
… all patients with relapsing-remitting or secondary progressive multiple sclerosis (RRMS; SPMS), who initiated Ofatumumab between January 2023 and…
migraineCMAtogepantNeurology DepartmentEthics Committee
…ts calcitonin gene-related peptide (CGRP) receptors involved in migraine development.Aim and Objectives To evaluate atogepant effectiven…
diabetic macular oedemawet age-related macular degenerationDMEAMDAflibercept
…the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME) in adults.Aim and Objectives To evaluate the use of aflib…
aGVHDaGVHD-cumulative-incidenceacute renal failureacute graft-versus-host diseaseaGVHD-relatedaGVHD-freeEuropean Society for Blood and Marrow TransplantationPHARALLOEBMT
…luded (37 intervention; 30 control).The cumulative incidence of aGVHD by day +100 was reduced by 13.4% in the intervention group (p=0…
Rheumatoid arthritisRAErelziBenepaliEnbrel
…Background and Importance Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic joint disease. Although…
migraineHeadacheCGRPgalcanezumaberenumabfremanezumab
…, anti-CGRP mAbs were associated with significant reductions in migraine frequency after 6 months. Galcanezumab showed the greatest mean…